1. A phase‐1, open‐label, single‐dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairment. (14th September 2015) Authors: Csonka, Denes; Hazell, Katharine; Waldron, Edward; Lorenzo, Sebastien; Duval, Vincent; Trandafir, Lucia; Kobalava, Zhanna D. Journal: Journal of clinical pharmacology Issue: Volume 56:Number 3(2016) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exposure–Efficacy Analysis of Asciminib in Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase. Issue 5 (31st July 2022) Authors: Combes, François Pierre; Li, Ying Fei; Hoch, Matthias; Lorenzo, Sebastien; Ho, Yu‐Yun; Sy, Sherwin K. B. Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 5(2022) Page Start: 1040 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗